Geoffrey M. Parker, Director at Better Therapeutics, Inc. (BTTX), bought 25,000 shares at $1.45 ($36K) on 2022-06-13, disclosed to the SEC on 2022-06-14.
Recurring purchase ($36k) by Director following this insider's established cadence. Pattern-driven, low signal.
Clearly above the average filing.
| Filing → |
| ALLO | SELL | 2025-10-23 | $46K | — | Filing → |
| PRGO | BUY | 2025-08-20 | $201K | — | Filing → |
| PRGO | BUY | 2025-05-14 | $95K | — | Filing → |